Correlation Between Canntab Therapeutics and Medipharm Labs
Can any of the company-specific risk be diversified away by investing in both Canntab Therapeutics and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Canntab Therapeutics and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Canntab Therapeutics Limited and Medipharm Labs Corp, you can compare the effects of market volatilities on Canntab Therapeutics and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Canntab Therapeutics with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Canntab Therapeutics and Medipharm Labs.
Diversification Opportunities for Canntab Therapeutics and Medipharm Labs
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Canntab and Medipharm is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Canntab Therapeutics Limited and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and Canntab Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Canntab Therapeutics Limited are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of Canntab Therapeutics i.e., Canntab Therapeutics and Medipharm Labs go up and down completely randomly.
Pair Corralation between Canntab Therapeutics and Medipharm Labs
Assuming the 90 days horizon Canntab Therapeutics Limited is expected to generate 6.24 times more return on investment than Medipharm Labs. However, Canntab Therapeutics is 6.24 times more volatile than Medipharm Labs Corp. It trades about 0.04 of its potential returns per unit of risk. Medipharm Labs Corp is currently generating about 0.01 per unit of risk. If you would invest 1.76 in Canntab Therapeutics Limited on November 2, 2024 and sell it today you would lose (1.75) from holding Canntab Therapeutics Limited or give up 99.43% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 99.8% |
Values | Daily Returns |
Canntab Therapeutics Limited vs. Medipharm Labs Corp
Performance |
Timeline |
Canntab Therapeutics |
Medipharm Labs Corp |
Canntab Therapeutics and Medipharm Labs Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Canntab Therapeutics and Medipharm Labs
The main advantage of trading using opposite Canntab Therapeutics and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Canntab Therapeutics position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.Canntab Therapeutics vs. Bionoid Pharma | Canntab Therapeutics vs. CTT Pharmaceutical Holdings | Canntab Therapeutics vs. Alterola Biotech | Canntab Therapeutics vs. HLS Therapeutics |
Medipharm Labs vs. Pharmacielo | Medipharm Labs vs. Blueberries Medical Corp | Medipharm Labs vs. Flora Growth Corp | Medipharm Labs vs. Stem Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |